Trademark: 87878584
Word
ADAPTIVE
Status Date
Monday, August 22, 2022
Filing Date
Monday, April 16, 2018
Published for Opposition
Tuesday, November 13, 2018
Abandoned Date
Monday, August 22, 2022
44 Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly
42 Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy
The mark consists of the word "Adaptive" with the "A" being capitalized and using a stylized helix to form half of the letter.
Color is not claimed as a feature of the mark.
Aug 22, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 22, 2022
Abandonment - No Use Statement Filed
Jul 15, 2022
Teas Change Of Correspondence Received
Jul 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 18, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 7, 2021
Ttab Release Case To Trademarks
Dec 7, 2021
Opposition Dismissed No. 999999
Dec 10, 2020
Case Assigned To Ttab
Dec 10, 2020
Notice Of Allowance Cancelled
Aug 18, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 8, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 8, 2020
Teas Change Of Correspondence Received
Jul 8, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 8, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 8, 2020
Teas Change Of Owner Address Received
Jul 7, 2020
Ttab Release Case To Trademarks
Jul 7, 2020
Opposition Terminated No. 999999
Jul 7, 2020
Opposition Dismissed No. 999999
Apr 16, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 16, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 19, 2018
Opposition Instituted No. 999999
Nov 19, 2018
Opposition Papers Received At Ttab
Nov 13, 2018
Official Gazette Publication Confirmation E-Mailed
Nov 13, 2018
Published For Opposition
Oct 24, 2018
Notification Of Notice Of Publication E-Mailed
Oct 5, 2018
Assigned To Lie
Sep 20, 2018
Approved For Pub - Principal Register
Sep 18, 2018
Teas/Email Correspondence Entered
Sep 17, 2018
Correspondence Received In Law Office
Sep 17, 2018
Teas Response To Office Action Received
Aug 8, 2018
Notification Of Non-Final Action E-Mailed
Aug 8, 2018
Non-Final Action E-Mailed
Aug 8, 2018
Non-Final Action Written
Aug 3, 2018
Assigned To Examiner
Apr 24, 2018
Notice Of Design Search Code E-Mailed
Apr 23, 2018
New Application Office Supplied Data Entered
Apr 19, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
